Rangaswamy Srinivasan | |
---|---|
Born | |
Alma mater | University of Madras, University of Southern California |
Known for | Ablative Photodecomposition, LASIK |
Awards | Russ Prize (2011) National Medal of Technology and Innovation (2012) |
Scientific career | |
Fields | Physical chemistry |
Institutions | IBM Research |
Rangaswamy Srinivasan (born February 28, 1929, in Madras, India [1] ) is a physical chemist and inventor with a 30-year career at IBM Research. He has developed techniques for ablative photodecomposition and used them to contribute to the development of LASIK eye surgery.
He received the National Medal of Technology from President Obama on February 2, 2013, for his contributions to laser eye surgery.
Srinivasan was born in India on February 28, 1929. [2] Srinivasan received both bachelor's and master's degrees in science from the University of Madras, in 1949 and 1950. [2] In 1953 he moved to the United States to attend graduate school. He earned a doctorate in physical chemistry at the University of Southern California in 1956, studying protein chemistry with chemical kineticist Sidney W. Benson. [3] He held postdoctoral positions at the California Institute of Technology in 1956, and at the University of Rochester from 1957 to 1961. [4]
Srinivasan has spent a thirty-year career, from 1961 to 1990, at IBM's T. J. Watson Research Center in Yorktown Heights, New York. He joined the research staff in 1961, and was promoted to "manager of fundamental photochemical research" in 1963. [5] His research group has studied ultraviolet light and its effects on organic matter. [4]
In 1981, Srinivasan and his coworkers determined that an ultraviolet excimer laser could be used to etch designs into polymers. The technique has since been used in the computer industry to drill polymers to create computer circuit boards and ink jet printer nozzles. [6]
Srinivasan, physicist James J. Wynne and materials scientist Samuel Blum speculated that it might also be possible to use excimer lasers on living tissue. On November 27, 1981, Srinivasan experimented with the remains of his family's Thanksgiving turkey, and proved that it was possible to create precisely-etched patterns. [5] [7] [8] An ultraviolet excimer laser pulsed at 193 nm was able to etch living tissue precisely without causing any thermal damage to surrounding area. Srinivasan named the technique Ablative Photodecomposition (APD), [4] a type of Laser ablation. [9]
In 1983, ophthalmic surgeon Stephen Trokel approached Srinivasan about the possibility of using APD for surgery of the cornea. The collaboration of Srinivasan, Trokel, and Bodil Braren led to development of LASIK eye surgery, a technique for reshaping the cornea to correct visual issues such as myopia, hyperopia and astigmatism. In 1995, a commercial system for laser refractive surgery was approved by the U.S. Food and Drug Administration. [7]
Srinivasan has published over 130 scientific papers and holds at least 22 US patents. [4] A patent application filed by Stephen Trokel in 1992, claiming a LASIK surgery technique as his sole invention, was declared invalid in 2000 by an International Trade Commission ruling that found that Srinivasan should have been included as a co-author. [10]
In 1990, Srinivasan formed a consulting company, UVTech Associates. [4]
External videos | |
---|---|
2013 Russ Prize, Ohio University |
In 1997, Srinivasan was awarded the American Chemical Society's Award for Creative Invention, [11] and the ACS North East Section's Esselen Medal. [12]
In 1998, Srinivasan was awarded the Max Delbruck Prize in Biological Physics by the American Physical Society. [13]
In 1999, he was elected a member of the National Academy of Engineering. [14]
In 2002, he was inducted into the US National Inventors Hall of Fame. [2]
In 2004, he received the Prize for Industrial Applications of Physics from the American Institute of Physics. [4] The same year, he, with Wynne and Blum, received the Optical Society's R. W. Wood Prize, "for their discovery of pulsed ultraviolet laser surgery, wherein laser light cuts and etches biological tissue by photoablation with minimal collateral damage, leading to healing without significant scarring."
In 2011, Srinivasan, Wynne, and Blum received the Fritz J. and Dolores H. Russ Prize from Ohio University and the National Academy of Engineering (NAE) for their work, "a bioengineering achievement that significantly improves the human condition." [5]
In 2012, Srinivasan, Wynne, and Blum were named as recipients of the National Medal of Technology and Innovation. [15] The award was presented on February 1, 2013, by President Barack Obama, to acknowledge their work with the Excimer laser, leading to the development of LASIK Surgery. [16] [17]
Photolithography is a process used in the manufacturing of integrated circuits. It involves using light to transfer a pattern onto a substrate, typically a silicon wafer.
Angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty (PTA), is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis.
LASIK or Lasik, commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and astigmatism. LASIK surgery is performed by an ophthalmologist who uses a femtosecond laser or a microkeratome to create a corneal flap to expose the corneal stroma and then an excimer laser to reshape the corneal stroma in order to improve visual acuity.
An excimer laser, sometimes more correctly called an exciplex laser, is a form of ultraviolet laser which is commonly used in the production of microelectronic devices, semiconductor based integrated circuits or "chips", eye surgery, and micromachining.
Refractive surgery is an optional eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea (keratomileusis), lens implantation or lens replacement. The most common methods today use excimer lasers to reshape the curvature of the cornea. Refractive eye surgeries are used to treat common vision disorders such as myopia, hyperopia, presbyopia and astigmatism.
A krypton fluoride laser is a particular type of excimer laser, which is sometimes called an exciplex laser. With its 248 nanometer wavelength, it is a deep ultraviolet laser which is commonly used in the production of semiconductor integrated circuits, industrial micromachining, and scientific research. The term excimer is short for 'excited dimer', while exciplex is short for 'excited complex'. An excimer laser typically contains a mixture of: a noble gas such as argon, krypton, or xenon; and a halogen gas such as fluorine or chlorine. Under suitably intense conditions of electromagnetic stimulation and pressure, the mixture emits a beam of coherent stimulated radiation as laser light in the ultraviolet range.
Mani Lal Bhaumik is an Indian American physicist and an internationally bestselling author, celebrated lecturer, entrepreneur and philanthropist.
Mark Cohen is a Canadian laser eye surgeon who practices in Montreal and Toronto. In 2001, he and Avi Wallerstein founded LASIK MD, Canada's largest provider of laser refractive surgery. As of 2013, LASIK MD performs over sixty percent of all laser vision correction procedures in Canada. He is one of only 14 certified C-LASIK instructors in North America.
Avi Wallerstein is a Canadian ophthalmologist and laser eye surgeon who specializes in surgical vision correction, also termed refractive eye surgery. He practises in Montreal and Toronto. In 2001, he co-founded LASIK MD with Mark Cohen. LASIK MD is Canada's largest provider of laser refractive surgery, performing over 60,000 procedures a year. He is one of only 14 certified CLasik instructors in North America.
Samuel E. Blum was an American chemist and physicist. He was a researcher at the Battelle Memorial Institute in Columbus, Ohio, working for government and private companies. He worked with semiconductor materials, which was his specialization until his retirement from IBM Watson Research Center in 1990.
The argon fluoride laser is a particular type of excimer laser, which is sometimes called an exciplex laser. With its 193-nanometer wavelength, it is a deep ultraviolet laser, which is commonly used in the production of semiconductor integrated circuits, eye surgery, micromachining, and scientific research. "Excimer" is short for "excited dimer", while "exciplex" is short for "excited complex". An excimer laser typically uses a mixture of a noble gas and a halogen gas, which under suitable conditions of electrical stimulation and high pressure, emits coherent stimulated radiation in the ultraviolet range.
Stephen Updegraff, M.D., FACS is an American refractive surgeon best known for his early involvement in, and contributions to, LASIK. He is a Fellow of the American College of Surgeons, a board-certified member of the American Board of Ophthalmology, a founding member of the American College of Ophthalmic Surgeons, and a member of the International Society of Refractive Surgery, the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Pine Ridge Eye Study Society. Updegraff currently serves as the medical director of Updegraff Vision in St. Petersburg, Florida.
Gholam A. Peyman is an Iranian American ophthalmologist, retina surgeon, and inventor. He is best known for his invention of LASIK eye surgery, a vision correction procedure designed to allow people to see clearly without glasses. He was awarded the first US patent for the procedure in 1989.
Jeffery J. Machat MD, FRCSC, DABO is an ophthalmologist in the United States and Canada specializing in surgical vision correction better known as refractive eye surgery. He is most known for being the Co-Founder of TLC Laser Eye Centers with Elias Vamvakas in 1993. The first TLC clinic was located in Windsor, Canada and treated thousands of patients from across all of North America. The clinic also hosted thousands of eye care specialists trying to learn about LASIK and PRK prior to US FDA approval which came three years later. Together Vamvakas and Machat built an incredible company of 83 LASIK clinics through both organic growth and strategic acquisition by May 2002 to become the largest provider of LASIK in North America. Dr. Machat pioneered not only LASIK but the concept of Optometric Comanagement throughout the 1990s, helping build a TLC network of over 14,000 referring optometrists by 2000. In 2005-2006, Machat spent time in Europe working to build Optical Express, helping David Moulsdale, owner and Founder, to transform the company from 300 optical stores into the leading provider of LASIK vision correction in Europe with 55 clinics in the span of 2 years.
Peter S. Hersh is an American ophthalmologist, researcher, and specialist in LASIK eye surgery, keratoconus, and diseases of the cornea. He co-authored the article in the journal Ophthalmology that presented the results of the study that led to the first approval by the U.S. Food and Drug Administration (FDA) of the excimer laser for the correction of nearsightedness in the United States. Hersh was also medical monitor of the study that led to approval of corneal collagen crosslinking for the treatment of keratoconus. He was the originator, in 2015, of CTAK for keratoconus, patent holder, and co-developer.
Raymond Mark Stein, MD, FRCSC, DABO, is a Canadian ophthalmologist. He practices refractive and cataract surgery. He is the medical director of the Bochner Eye Institute in Toronto, Ontario and Chief of Ophthalmology at the Scarborough General Hospital.
James J. Wynne is an American physicist at the IBM Watson Research Center in Yorktown Heights, NY.
The Katharine Burr Blodgett Medal and Prize is a gold medal awarded annually by the Institute of Physics to "recognise contributions to the organisation or application of physics in an industrial or commercial context." The medal is accompanied by a prize of £1000.
John Marshall MBE, FMedSci, PhD, DSc, FRCPath, FRSB, FRCOphth(Hon), FRCOptom (Hon), FARVO is a British medical scientist and inventor. Currently he is the Frost Professor of Ophthalmology at the Institute of Ophthalmology UCL and Emeritus Professor King's College London. He is a pioneer of laser eye surgery.
Ursula Keller is a Swiss physicist. She has been a physics professor at the ETH Zurich, Switzerland since 2003 with a speciality in ultra-fast laser technology, an inventor and the winner of the 2018 European Inventor Award by the European Patent Office.